|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-1-5
|
|
pubmed:abstractText |
The objective of this study was to systematically characterize the incidence and determinants of antiretroviral resistance in the HOMER (Highly Active Antiretroviral Therapy [HAART] Observational Medical Evaluation and Research) cohort of 1191 human immunodeficiency virus-infected, antiretroviral-naive adults initiating HAART in British Columbia, Canada.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0022-1899
|
|
pubmed:author |
pubmed-author:AlexanderChris SCS,
pubmed-author:BrummeChanson JCJ,
pubmed-author:BrummeZabrina LZL,
pubmed-author:DongWinnie W YWW,
pubmed-author:HarriganP RichardPR,
pubmed-author:HoggRobert SRS,
pubmed-author:MoTheresaT,
pubmed-author:MontanerJulio S GJS,
pubmed-author:WoodwardJustinJ,
pubmed-author:WynhovenBrianB,
pubmed-author:YipBenitaB
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
191
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
339-47
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15633092-Adult,
pubmed-meshheading:15633092-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15633092-British Columbia,
pubmed-meshheading:15633092-CD4 Lymphocyte Count,
pubmed-meshheading:15633092-Drug Resistance, Viral,
pubmed-meshheading:15633092-HIV Infections,
pubmed-meshheading:15633092-HIV Protease,
pubmed-meshheading:15633092-HIV Reverse Transcriptase,
pubmed-meshheading:15633092-HIV-1,
pubmed-meshheading:15633092-Humans,
pubmed-meshheading:15633092-Incidence,
pubmed-meshheading:15633092-Multivariate Analysis,
pubmed-meshheading:15633092-Mutation,
pubmed-meshheading:15633092-Patient Compliance,
pubmed-meshheading:15633092-Viral Load
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.
|
|
pubmed:affiliation |
British Columbia Centre for Excellence in HIV/AIDS, and Department of Medicine, University of British Columbia, Vancouver, Canada. lab@hivnet.ubc.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
